Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?
This medical laboratory operator has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 2.21%.
For the last reported quarter, Labcorp came out with earnings of $3.84 per share versus the Zacks Consensus Estimate of $3.73 per share, representing a surprise of 2.95%. For the previous quarter, the company was expected to post earnings of $3.4 per share and it actually produced earnings of $3.45 per share, delivering a surprise of 1.47%.
Price and EPS Surprise
Thanks in part to this history, there has been a favorable change in earnings estimates for Labcorp lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Labcorp currently has an Earnings ESP of +0.51%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 24, 2025.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Labcorp Holdings Inc. (LH) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Fehler beim Abrufen der Daten
Melden Sie sich an, um Ihr Portfolio aufzurufen.
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
COIN to Report Q2 Earnings: Will Higher Trading Volume Fuel Growth?
Coinbase Global COIN is set to report second-quarter 2025 results on July 31, after market close. This company beat estimates in three of the last four reported quarters and matched in discuss the factors that are likely to be reflected in the upcoming quarterly volume in the second quarter is likely to have improved owing to increased asset volatility and improved crypto asset prices. Crypto trading remains a major revenue driver for COIN. It has been prioritizing crypto utility by investing in infrastructure and foundational market share in the U.S. spot and derivatives markets and an expanded product portfolio and international market presence are likely to have added to the upside. The company is likely to have benefited from the acquisition of Deribit, the world's leading crypto options exchange, in the quarter. This makes Coinbase the leading crypto derivative platform globally by open Zacks Consensus Estimate for total trading volume is pegged at 249 million, indicating an improvement of 10.1% from the year-ago reported number. The consensus estimate for total volume - Consumer is pegged at 46.1 million, suggesting a 25% increase from the year-ago reported number. The consensus mark for total volume - Institution is pegged at 203 million, indicating a surge of 7.4% from the year-ago reported revenues are likely to have benefited from higher fees for Consumer and Institutional. The Zacks Consensus Estimate for transaction revenues is pegged at $759 billion, indicating an increase of 23% from the year-ago reported Zacks Consensus Estimate for transaction revenues - Consumer is pegged at $647 million. The consensus estimate for transaction revenues - Institutional is pegged at $54 are likely to have benefited from market share gains in U.S. spot and derivatives trading, along with increased volumes in custody, staking and USDC assets, as well as growth in Coinbase One subscriptions. What Our Quantitative Model Predicts Our proven model predicts an earnings beat for Coinbase this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), which increases the odds of an earnings beat. Earnings ESP: Coinbase's Earnings ESP is +12.05%. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. Coinbase Global, Inc. Price and EPS Surprise Coinbase Global, Inc. price-eps-surprise | Coinbase Global, Inc. Quote Zacks Rank: Coinbase currently has a Zacks Rank #3. You can see the complete list of today's Zacks #1 Rank stocks here. Other Stocks to Consider Euronet Worldwide EEFT has an Earnings ESP of +2.53% and a Zacks Rank of 2 at present. The Zacks Consensus Estimate for second-quarter 2025 earnings is pegged at $2.63 per share, indicating an increase of 16.9% from the year-ago reported figure. EEFT's earnings beat estimates in only one of the last four quarters, met in two and missed in Lokey HLI has an Earnings ESP of +0.99% and carries a Zacks Rank of 3 at present. The Zacks Consensus Estimate for second-quarter 2025 earnings is pegged at $1.69, indicating a surge of 38.5% from the year-ago reported earnings beat estimates in three of the last four quarters, while missing in & Co. Inc. INTR has an Earnings ESP of +5.41% and a Zacks Rank of 3 at present. The Zacks Consensus Estimate for second-quarter 2025 earnings is pegged at 12 cents per share, indicating an increase of 33% from the year-ago reported earnings beat estimates in two of the last four quarters, met in one and missed in one. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Euronet Worldwide, Inc. (EEFT) : Free Stock Analysis Report Houlihan Lokey, Inc. (HLI) : Free Stock Analysis Report Coinbase Global, Inc. (COIN) : Free Stock Analysis Report Inter & Co. Inc. (INTR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
BellRing Brands (BRBR) Exceeds Market Returns: Some Facts to Consider
BellRing Brands (BRBR) ended the recent trading session at $55.51, demonstrating a +1.41% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 0.02%. Meanwhile, the Dow lost 0.14%, and the Nasdaq, a tech-heavy index, added 0.33%. The stock of nutritional supplements company has fallen by 6.49% in the past month, lagging the Consumer Staples sector's gain of 1.1% and the S&P 500's gain of 4.93%. Market participants will be closely following the financial results of BellRing Brands in its upcoming release. The company plans to announce its earnings on August 4, 2025. In that report, analysts expect BellRing Brands to post earnings of $0.49 per share. This would mark a year-over-year decline of 9.26%. Simultaneously, our latest consensus estimate expects the revenue to be $531.85 million, showing a 3.19% escalation compared to the year-ago quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $2.2 per share and revenue of $2.3 billion, indicating changes of +13.99% and +15.42%, respectively, compared to the previous year. Any recent changes to analyst estimates for BellRing Brands should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. BellRing Brands presently features a Zacks Rank of #3 (Hold). In terms of valuation, BellRing Brands is presently being traded at a Forward P/E ratio of 24.84. This represents a premium compared to its industry average Forward P/E of 16.81. Also, we should mention that BRBR has a PEG ratio of 1.78. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As of the close of trade yesterday, the Food - Miscellaneous industry held an average PEG ratio of 1.67. The Food - Miscellaneous industry is part of the Consumer Staples sector. With its current Zacks Industry Rank of 161, this industry ranks in the bottom 35% of all industries, numbering over 250. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow BRBR in the coming trading sessions, be sure to utilize Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BellRing Brands Inc. (BRBR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
Hims & Hers Health, Inc. (HIMS) Outperforms Broader Market: What You Need to Know
Hims & Hers Health, Inc. (HIMS) closed at $58.68 in the latest trading session, marking a +1.79% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.02%. Meanwhile, the Dow experienced a drop of 0.14%, and the technology-dominated Nasdaq saw an increase of 0.33%. The stock of company has risen by 16.68% in the past month, leading the Medical sector's gain of 1.92% and the S&P 500's gain of 4.93%. The investment community will be closely monitoring the performance of Hims & Hers Health, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on August 4, 2025. On that day, Hims & Hers Health, Inc. is projected to report earnings of $0.18 per share, which would represent year-over-year growth of 200%. At the same time, our most recent consensus estimate is projecting a revenue of $551.84 million, reflecting a 74.83% rise from the equivalent quarter last year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.75 per share and a revenue of $2.35 billion, signifying shifts of +177.78% and +58.88%, respectively, from the last year. Investors should also note any recent changes to analyst estimates for Hims & Hers Health, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.27% higher. Right now, Hims & Hers Health, Inc. possesses a Zacks Rank of #1 (Strong Buy). From a valuation perspective, Hims & Hers Health, Inc. is currently exchanging hands at a Forward P/E ratio of 77.22. This expresses a premium compared to the average Forward P/E of 27.59 of its industry. Also, we should mention that HIMS has a PEG ratio of 2.13. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The average PEG ratio for the Medical Info Systems industry stood at 3.15 at the close of the market yesterday. The Medical Info Systems industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 74, finds itself in the top 30% echelons of all 250+ industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
